TrialNaunyn-Schmiedeberg's archives of pharmacology2026
Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.
Bahram Shahri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.